118 related articles for article (PubMed ID: 35170591)
1. Extracellular vesicle-mediated co-delivery of TRAIL and dinaciclib for targeted therapy of resistant tumors.
Ke C; Hou H; Su K; Huang C; Yuan Q; Li S; Sun J; Lin Y; Wu C; Zhao Y; Yuan Z
Biomater Sci; 2022 Mar; 10(6):1498-1514. PubMed ID: 35170591
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary Delivery of Extracellular Vesicle-Encapsulated Dinaciclib as an Effective Lung Cancer Therapy.
Yuan Q; Su K; Li S; Long X; Liu L; Yang M; Yuan X; Sun J; Hu J; Li Q; Zhao Y; Yuan Z
Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884614
[TBL] [Abstract][Full Text] [Related]
3. EV-T synergizes with AZD5582 to overcome TRAIL resistance through concomitant suppression of cFLIP, MCL-1, and IAPs in hepatocarcinoma.
Su K; Yuan Q; Hou H; Ke C; Huang C; Li S; Sun J; Yuan X; Lin Y; Chen Y; Xin H; Liang X; Du Z; Yuan Z
J Mol Med (Berl); 2022 Apr; 100(4):629-643. PubMed ID: 35247069
[TBL] [Abstract][Full Text] [Related]
4. Extracellular Vesicle Delivery of TRAIL Eradicates Resistant Tumor Growth in Combination with CDK Inhibition by Dinaciclib.
Ke C; Hou H; Li J; Su K; Huang C; Lin Y; Lu Z; Du Z; Tan W; Yuan Z
Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32375399
[TBL] [Abstract][Full Text] [Related]
5. Selective CDK9 knockdown sensitizes TRAIL response by suppression of antiapoptotic factors and NF-kappaB pathway.
Yuan Q; Su K; Li S; Long X; Liu L; Sun J; Yuan X; Yang M; Tian R; Zhang W; Deng Z; Li Q; Ke C; He Y; Cheng C; Yuan J; Wen Z; Zhou W; Yuan Z
Apoptosis; 2023 Aug; 28(7-8):1060-1075. PubMed ID: 37060507
[TBL] [Abstract][Full Text] [Related]
6. Selective CDK9 inhibition overcomes TRAIL resistance by concomitant suppression of cFlip and Mcl-1.
Lemke J; von Karstedt S; Abd El Hay M; Conti A; Arce F; Montinaro A; Papenfuss K; El-Bahrawy MA; Walczak H
Cell Death Differ; 2014 Mar; 21(3):491-502. PubMed ID: 24362439
[TBL] [Abstract][Full Text] [Related]
7. Pre-therapeutic efficacy of the CDK inhibitor dinaciclib in medulloblastoma cells.
Buzzetti M; Morlando S; Solomos D; Mehmood A; Cox AWI; Chiesa M; D'Alessandra Y; Garofalo M; Topham CH; Di Leva G
Sci Rep; 2021 Mar; 11(1):5374. PubMed ID: 33686114
[TBL] [Abstract][Full Text] [Related]
8. CDK9 inhibition as an effective therapy for small cell lung cancer.
Valdez Capuccino L; Kleitke T; Szokol B; Svajda L; Martin F; Bonechi F; Krekó M; Azami S; Montinaro A; Wang Y; Nikolov V; Kaiser L; Bonasera D; Saggau J; Scholz T; Schmitt A; Beleggia F; Reinhardt HC; George J; Liccardi G; Walczak H; Tóvári J; Brägelmann J; Montero J; Sos ML; Őrfi L; Peltzer N
Cell Death Dis; 2024 May; 15(5):345. PubMed ID: 38769311
[TBL] [Abstract][Full Text] [Related]
9. TRAIL delivery by MSC-derived extracellular vesicles is an effective anticancer therapy.
Yuan Z; Kolluri KK; Gowers KH; Janes SM
J Extracell Vesicles; 2017; 6(1):1265291. PubMed ID: 28326166
[TBL] [Abstract][Full Text] [Related]
10. CDK1/2/5 inhibition overcomes IFNG-mediated adaptive immune resistance in pancreatic cancer.
Huang J; Chen P; Liu K; Liu J; Zhou B; Wu R; Peng Q; Liu ZX; Li C; Kroemer G; Lotze M; Zeh H; Kang R; Tang D
Gut; 2021 May; 70(5):890-899. PubMed ID: 32816920
[TBL] [Abstract][Full Text] [Related]
11. The plant alkaloid and anti-leukemia drug homoharringtonine sensitizes resistant human colorectal carcinoma cells to TRAIL-induced apoptosis via multiple mechanisms.
Beranova L; Pombinho AR; Spegarova J; Koc M; Klanova M; Molinsky J; Klener P; Bartunek P; Andera L
Apoptosis; 2013 Jun; 18(6):739-50. PubMed ID: 23456623
[TBL] [Abstract][Full Text] [Related]
12. The pleiotropic profile of the indirubin derivative 6BIO overcomes TRAIL resistance in cancer.
Braig S; Bischoff F; Abhari BA; Meijer L; Fulda S; Skaltsounis L; Vollmar AM
Biochem Pharmacol; 2014 Sep; 91(2):157-67. PubMed ID: 25069048
[TBL] [Abstract][Full Text] [Related]
13. Downmodulation of dimethyl transferase activity enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in prostate cancer cells.
Festuccia C; Gravina GL; D'Alessandro AM; Millimaggi D; Di Rocco C; Dolo V; Ricevuto E; Vicentini C; Bologna M
Int J Oncol; 2008 Aug; 33(2):381-8. PubMed ID: 18636160
[TBL] [Abstract][Full Text] [Related]
14. Maritoclax and dinaciclib inhibit MCL-1 activity and induce apoptosis in both a MCL-1-dependent and -independent manner.
Varadarajan S; Poornima P; Milani M; Gowda K; Amin S; Wang HG; Cohen GM
Oncotarget; 2015 May; 6(14):12668-81. PubMed ID: 26059440
[TBL] [Abstract][Full Text] [Related]
15. The Novel, Orally Bioavailable CDK9 Inhibitor Atuveciclib Sensitises Pancreatic Cancer Cells to TRAIL-induced Cell Death.
Ruff JP; Kretz AL; Kornmann M; Henne-Bruns D; Lemke J; Traub B
Anticancer Res; 2021 Dec; 41(12):5973-5985. PubMed ID: 34848451
[TBL] [Abstract][Full Text] [Related]
16. Ibulocydine sensitizes human hepatocellular carcinoma cells to TRAIL-induced apoptosis via calpain-mediated Bax cleavage.
Park SS; Jwa E; Shin SH; Ju EJ; Park I; Pak JH; Hwang JJ; Cho DH; Kim BM; Kim SB; Lee JS; Song SY; Jeong SY; Choi EK
Int J Biochem Cell Biol; 2017 Feb; 83():47-55. PubMed ID: 27923747
[TBL] [Abstract][Full Text] [Related]
17. TRAIL-induced apoptosis of hepatocellular carcinoma cells is augmented by targeted therapies.
Koehler BC; Urbanik T; Vick B; Boger RJ; Heeger S; Galle PR; Schuchmann M; Schulze-Bergkamen H
World J Gastroenterol; 2009 Dec; 15(47):5924-35. PubMed ID: 20014456
[TBL] [Abstract][Full Text] [Related]
18. Cytochalasin B-induced membrane vesicles from human mesenchymal stem cells overexpressing TRAIL, PTEN and IFN-β1 can kill carcinoma cancer cells.
Chulpanova DS; Gilazieva ZE; Akhmetzyanova ER; Kletukhina SK; Rizvanov AA; Solovyeva VV
Tissue Cell; 2021 Dec; 73():101664. PubMed ID: 34678531
[TBL] [Abstract][Full Text] [Related]
19. Suppression of apoptosis inhibitor c-FLIP selectively eliminates breast cancer stem cell activity in response to the anti-cancer agent, TRAIL.
Piggott L; Omidvar N; Martí Pérez S; French R; Eberl M; Clarkson RW
Breast Cancer Res; 2011 Sep; 13(5):R88. PubMed ID: 21914219
[TBL] [Abstract][Full Text] [Related]
20. CRISPR-mediated upregulation of DR5 and downregulation of cFLIP synergistically sensitize HeLa cells to TRAIL-mediated apoptosis.
Poondla N; Chandrasekaran AP; Heese K; Kim KS; Ramakrishna S
Biochem Biophys Res Commun; 2019 Apr; 512(1):60-65. PubMed ID: 30862357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
